drugset / Trial / NCT00345800
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
NaSingle-groupOpen-labelTreatment
Summary
To monitor for endocrine changes in response to treatment of cataplexy with Xyrem, to focus on the hypothalamic pituitary axis and to confirm the safety of Xyrem on potential endocrine changes.
Timeline
- Start
- 2006-04-10
- Primary completion
- 2008-01-22
- Completion
- 2008-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Oxybate | Unknown | 4.5 g | Oral |
| Subject | Sodium Oxybate | Unknown | 9 g | Oral |